Are you a new member? Sign up now
Login area
| Sign up
close
MABIXEN 100 - 100mg/10ml - 2x10ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 10810 | 89321/1 | MABIXEN 100 | 100mg/10ml | 2x10ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 22,183,393 L.L | 19.35 | D | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 11668 | 130723/1 | MABIXEN 100 | 100mg/10ml | 1x10ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 11,091,696 L.L | 19.35 | D | 2/5/2024 | 0 | ||
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 5574 | 219561/09 | MABTHERA | 100mg/10ml | 2 | Injectable concentrated solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 35,722,424 L.L | 10.71 | E1 | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg | 11602 | 107223/1 | RITUXIREL | 100mg/10ml | 1x10ml | Injectable concentrated solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | 11,708,063 L.L | 21.26 | C | Reliance Life Sciences pvt Ltd | India | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 9384 | 42018/1 | RIXATHON | 100mg/10ml | 2 x 10ml | Injectable concentrate for solution | Infusion | Khalil Fattal & Fils S.A.L. | Lek Pharmaceuticals dd | Slovenia | 33,968,541 L.L | 19.35 | D | Sandoz GmbH | Austria | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 11622 | 14023/1 | RUXIENCE | 100mg/10ml | 1x10ml | Injectable concentrate for solution | Infusion | Droguerie Fattal S.A.L. | Pfizer Manufacturing Belgium NV | Belgium | 13,157,756 L.L | 19.35 | D | Pfizer Europe MA EEIG | Belgium | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 10673 | 195819/1 | TRUXIMA | 100mg/10ml | 2x10ml | Injectable concentrate for solution | Infusion | Droguerie Mercury S.A.L. | Celltrion Inc. | Korea | 31,103,060 L.L | 19.35 | D | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg/10ml | 10029 | 125619/1 | ZYTUX | 100mg/10ml | 2x10ml | Injectable concentrate for solution | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 16,463,240 L.L | 19.35 | D | Aryogen Pharmed | Iran | 2/5/2024 | 0 |
| L01FA01 | BioTech | Rituximab - 100mg | 11602/388 | 107223/1 | RITUXIREL | 100mg/10ml | 1x10ml | Injectable concentrated solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | L.L | 21.26 | C | Reliance Life Sciences pvt Ltd | India | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024